Aerpio Therapeutics


Aerpio Therapeutics is a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. Aerpio is a leader in the development of small molecule drugs based on Tie2 activation and the stabilization of hypoxia-inducible factor 1α (HIF‐1α). The Company's lead program, AKB‐9778, is a first‐in‐class stabilizer of the Tie2 pathway and is in clinical development for diabetic macular edema.

Aerpio Therapeutics is a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. Aerpio is a leader in the development of small molecule drugs based on Tie2 activation and the stabilization of hypox...Show all

Company (IPO / Went public)

Phone: 513-985-1920

Fax:

9987 Carver Road
Suite 420
Cincinnati, 45242
Ohio, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aerpio Therapeutics $66M Mar 16, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aerpio Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Combination of immunotherapies with activators of tie-2 Aug 06, 2015 Jan 10, 2017 Patent
Prolyl hydroxylase inhibitors Apr 16, 2015 Jan 10, 2017 Patent
Compositions, formulations and methods for treating ocular diseases Mar 14, 2014 Sep 13, 2016 Patent
Process for preparing n-benzyl-3-hydroxy-4-substituted-pyridin-2-(1h)-ones Feb 18, 2015 Jul 12, 2016 Patent
Human protein tyrosine phosphatase inhibitors and methods of use Apr 14, 2014 Mar 15, 2016 Patent
See all 38 patents